content top

TEDxCaltech – Mark E. Davis – Nanomedicines: Nanobiotech v. Cancer

Mark E. Davis is the Warren and Katharine Schlinger Professor of Chemical Engineering at Caltech and a member of the Experimental Therapeutics Program of the Comprehensive Cancer Center at the City of Hope. He has over 350 scientific publications, two textbooks, and over 50 patents. He is the recipient of numerous awards, and was the first engineer to win the NSF Alan T. Waterman Award. He was elected in the National Academy of Engineering in 1997 and the National Academy of Sciences in 2006. Mark’s research efforts involve materials synthesis in two general areas; namely, solids that can be used for molecular recognition and catalysis, and polymers for the delivery of a broad range of therapeutics. He is the founder of two biotech companies. Professor Davis has achieved All American Status for Masters Track and Field in both the 400 Meter and 200 Meter Dashes. About TEDx, x = independently organized event: In the spirit of ideas worth spreading, TEDx is a program of local, self-organized events that bring people together to share a TED-like experience. At a TEDx event, TEDTalks video and live speakers combine to spark deep discussion and connection in a small group. These local, self-organized events are branded TEDx, where x = independently organized TED event. The TED Conference provides general guidance for the TEDx program, but individual TEDx events are self-organized. (Subject to certain rules and regulations.) On January 14, 2011, Caltech hosted TEDxCaltech, an
Video Rating: 5 / 5

Read More

Nanotechnology for Targeted Cancer Therapy

A short animation outlining the fundamentals of targeted nanomedicine for cancer therapy, one of our group’s primary research focuses. For more information, see nanomedicine.uwaterloo.ca © 2010 University of Waterloo Frank Gu Research Group Waterloo Institute for Nanotechnology Department of Chemical Engineering
Video Rating: 4 / 5

Read More

Nanoparticles for Cancer Treatment

Nanoparticles have a unique ability to target cancer cells and wipe out tumors. At Brigham and Womens Hospital, development of these new technologies holds tremendous promise for cancer treatment.
Video Rating: 5 / 5

Incoming search terms:

Read More

Question to Michel Marty about benefit/risk in nanomedicine

On the occasion of the International Day for Fight against Cancer on February 4th 2011, Pr. Michel Marty has been interviewed by Alain Baritault about the benefits that nanomedicine can bring to the oncology field and the risks that could possibly be associated.

Incoming search terms:

Read More

Cancer and Drug Delivery – Targeted Drug-carrying Phage Nanomedicines

Lecturer: Prof. Itai Benhar, Faculty of Life Sciences, TAU “From Discovery to Products: Innovative Technologies from Tel Aviv University” An event that was held at the Tel Aviv University, 28/5/08
Video Rating: 0 / 5

Read More
Page 1 of 212
content top